Oculis Holding AG | Small-cap | Healthcare
$18.56
5.61%
| Oculis Holding AG Stock Comparison:
Oculis Holding AG vs VertexOculis Holding AG vs RegeneronOculis Holding AG vs Vera TherapeuticsOculis Holding AG vs Dyne TherapeuticsOculis Holding AG vs LiquidiaOculis Holding AG vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 0
Operating Income -26.1M
Net Income -31.9M
EPS (Diluted) $-0.49

Balance Sheet Metrics

Total Assets 228.2M
Total Liabilities 48.4M
Shareholders Equity 179.8M
Debt to Equity 0.27

Cash Flow Metrics

Operating Cash Flow -18.7M
Free Cash Flow -21.8M

Revenue & Profitability Trend

Oculis Holding AG Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i00000
Cost of Goods Sold i-----
Gross Profit i-----
Gross Margin % i0.0%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i65.4M29.2M22.2M9.6M9.3M
Selling, General & Administrative i23.8M14.7M6.7M4.1M3.5M
Other Operating Expenses i2.6M1.8M3.3M-482.0K-555.0K
Total Operating Expenses i91.8M45.8M32.3M13.2M12.3M
Operating Income i-92.0M-45.9M-32.4M-13.2M-12.3M
Operating Margin % i0.0%0.0%0.0%0.0%0.0%
Non-Operating Items
Interest Income i2.7M1.4M126.0K21.0K10.0K
Interest Expense i802.8K1.3M6.4M5.1M2.6M
Other Non-Operating Income-17.9M-43.0M49.0K-193.0K163.0K
Pre-tax Income i-108.0M-88.7M-38.6M-18.5M-14.8M
Income Tax i-201.0K107.0K55.0K27.0K83.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-107.8M-88.8M-38.7M-18.6M-14.9M
Net Margin % i0.0%0.0%0.0%0.0%0.0%
Key Metrics
EBITDA i-88.7M-44.1M-32.0M-13.0M-12.1M
EPS (Basic) i$-2.12$-2.97$-1.18$-0.57$-0.45
EPS (Diluted) i$-2.12$-2.97$-1.18$-0.57$-0.45
Basic Shares Outstanding i5076719426410372294109362941093629410936
Diluted Shares Outstanding i5076719426410372294109362941093629410936

Income Statement Trend

Oculis Holding AG Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i34.8M38.3M19.8M46.3M5.0M
Short-term Investments i89.1M53.3M0--
Accounts Receivable i-----
Inventory i-----
Other Current Assets----1.0K
Total Current Assets i131.8M101.0M23.7M48.0M6.2M
Non-Current Assets
Property, Plant & Equipment i2.4M1.4M1.4M1.4M1.5M
Goodwill i16.7M12.2M12.2M8.7M8.7M
Intangible Assets i16.7M12.2M12.2M8.7M-
Long-term Investments-----
Other Non-Current Assets598.1K89.0K98.0K-1.0K6.0K
Total Non-Current Assets i19.4M13.3M13.4M10.1M10.2M
Total Assets i151.2M114.4M37.1M58.0M16.4M
Liabilities
Current Liabilities
Accounts Payable i7.4M7.6M3.9M824.0K790.0K
Short-term Debt i395.8K174.0K142.0K193.0K188.0K
Current Portion of Long-term Debt-----
Other Current Liabilities24.9M5.4M1.0K--1.0K
Total Current Liabilities i55.6M19.1M12.0M4.1M4.3M
Non-Current Liabilities
Long-term Debt i1.1M431.0K491.0K577.0K645.0K
Deferred Tax Liabilities i--011.0K0
Other Non-Current Liabilities--122.4M113.5M54.0M
Total Non-Current Liabilities i3.4M1.5M123.0M114.9M55.7M
Total Liabilities i59.0M20.6M135.1M119.0M60.0M
Equity
Common Stock i560.4K366.0K39.0K335.0K297.0K
Retained Earnings i-358.8M-199.8M-111.0M-72.3M-53.7M
Treasury Stock i12.6K01.0K100.0K100.0K
Other Equity-----
Total Shareholders Equity i92.2M93.7M-98.0M-61.0M-43.7M
Key Metrics
Total Debt i1.5M605.0K633.0K770.0K833.0K
Working Capital i76.2M81.9M11.6M43.9M1.8M

Balance Sheet Composition

Oculis Holding AG Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-108.0M-88.7M-38.6M-18.5M-14.8M
Depreciation & Amortization i510.1K287.0K299.0K235.0K228.0K
Stock-Based Compensation i12.3M3.6M804.0K328.0K328.0K
Working Capital Changes i4.3M-1.8M1.1M-439.0K-240.0K
Operating Cash Flow i-94.2M-47.0M-30.6M-12.4M-11.9M
Investing Activities
Capital Expenditures i-289.0K-48.0K-65.0K-28.0K-19.0K
Acquisitions i-----
Investment Purchases i-21.8M-54.2M00-
Investment Sales i-----
Investing Cash Flow i-22.1M-54.2M-65.0K-28.0K-19.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-344.3K-158.0K-159.0K-98.0K-98.0K
Financing Cash Flow i63.3M127.9M1.6M55.2M4.9M
Free Cash Flow i-60.0M-53.9M-28.6M-13.9M-12.0M
Net Change in Cash i-53.0M26.7M-29.0M42.7M-7.0M

Cash Flow Trend

Oculis Holding AG Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 63.63
Forward P/E -7.84
Price to Book 6.43
Price to Sales 1,203.59
PEG Ratio -16.23

Profitability Ratios

Profit Margin 0.00%
Operating Margin -7,957.09%
Return on Equity -83.96%
Return on Assets -29.71%

Financial Health

Current Ratio 4.55
Debt to Equity 0.72
Beta 0.13

Per Share Data

EPS (TTM) $-2.91
Book Value per Share $2.73
Revenue per Share $0.02

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ocs919.5M63.636.43-83.96%0.00%0.72
Vertex 103.4B28.686.0222.77%31.86%8.89
Regeneron 63.8B15.132.0915.34%31.37%9.04
Vera Therapeutics 2.0B-10.964.11-54.84%0.00%16.56
Dyne Therapeutics 2.0B-3.882.61-61.32%0.00%21.19
Liquidia 1.9B-13.51126.72-389.13%58.00%1,319.26

Financial data is updated regularly. All figures are in the company's reporting currency.